NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel
The DOI matches its Crossref record.
Abstract
This report represents the consensus of a panel of representatives from psychiatry, psychology, pharmacology, epidemiology, internal medicine, and the general public regarding the use of pharmacologic agents to prevent recurrences of mood disorders. The panel concluded that recurrent mood disorders, which have a high prevalence and serious consequences, are underdiagnosed and undertreated. Applying appropriate strategies to the management and use of pharmacologic agents will enhance the likelihood of compliance and the prevention of recurrence with a minimum of bothersome side effects. Such strategies should be used within the context of a supportive relationship among doctor, patient, and family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477
Comparison of Standard and Low Serum Levels of Lithium for Maintenance Treatment of Bipolar Disorder
Gelenberg, A. J., Kane, J. M., Keller, M. B., Lavori, P., Rosenbaum, J. F., Cole, K., & Lavelle, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212201 · Cited by 448
Changes in regional cerebral blood flow on recovery from depression
Bench, C. J., Frackowiak, R. S. J., & Dolan, R. J. (1995) · Psychological Medicine · doi:10.1017/s0033291700036151 · Cited by 351
Keller, M. B., & Boland, R. J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00110-3 · Cited by 281
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.6.795 · Cited by 228
Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis
Severus, E., Taylor, M. J., Sauer, C., Pfennig, A., Ritter, P., Bauer, M., & Geddes, J. R. (2014) · International Journal of Bipolar Disorders · doi:10.1186/s40345-014-0015-8 · Cited by 216
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Amygdala Reactivity and Mood-Congruent Memory in Individuals at Risk for Depressive Relapse
Ramel, W., Goldin, P. R., Eyler, L. T., Brown, G. G., Gotlib, I. H., & McQuaid, J. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.004 · Cited by 140
Lau, M. A., & McMain, S. F. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505001310 · Cited by 112
Lithium versus antidepressants in the long-term treatment of unipolar affective disorder
Cipriani, A., Smith, K. A., Burgess, S. S., Carney, S. M., Goodwin, G., & Geddes, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003492.pub2 · Cited by 91
Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01356.x · Cited by 90
Steps Following Attainment of Remission: Discontinuation of Antidepressant
Shelton, R. C. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0404 · Cited by 43
Rickels, K., Montgomery, S. A., Tourian, K. A., Guelfi, J. D., Pitrosky, B., Padmanabhan, S. K., Germain, J.-M., Leurent, C., & Brisard, C. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c94c4d · Cited by 33
Kok, G., van Rijsbergen, G., Burger, H., Elgersma, H., Riper, H., Cuijpers, P., Dekker, J., Smit, F., & Bockting, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111711 · Cited by 9
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1985-04-01
- Volume
- 142
- Issue
- 4
- Pages
- 469-476
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W4255508296
- Cited by
- 152
- References
- 0
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.